MRK vs ZTS
By Alex · Tickerpine
Merck & Co., Inc. vs Zoetis Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | ZTS |
|---|---|---|
| Price | $147.76 | $83.82 |
| Market cap | $364.26B | $34.06B |
| P/E ratio | 149.3 | 14.3 |
| ROE | 5.06% | 57.63% |
| Profit margin | 3.64% | 26.41% |
| Revenue growth | 4.70% | -1.30% |
| Dividend yield | 2.30% | 2.53% |
| Beta | 0.12 | 0.68 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs ZTS in plain English
- MRK is the bigger company — about 10.7× the market cap of ZTS.
- ZTS is cheaper on earnings (P/E 14.3 vs 149.3).
- ZTS earns a higher return on equity (58% vs 5%).
- MRK is growing revenue faster (5% vs -1%).
- ZTS has the higher dividend yield (2.53% vs 2.30%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
ZTS return calculator
See what $1,000 in Zoetis Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.